536 related articles for article (PubMed ID: 35091640)
1. Impact of vaccination on the COVID-19 pandemic in U.S. states.
Chen X; Huang H; Ju J; Sun R; Zhang J
Sci Rep; 2022 Jan; 12(1):1554. PubMed ID: 35091640
[TBL] [Abstract][Full Text] [Related]
2. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 pandemic and vaccination build herd immunity.
Redwan EM
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):577-579. PubMed ID: 33577008
[No Abstract] [Full Text] [Related]
4. Population Immunity Against COVID-19 in the United States.
Moghadas SM; Sah P; Shoukat A; Meyers LA; Galvani AP
Ann Intern Med; 2021 Nov; 174(11):1586-1591. PubMed ID: 34516275
[TBL] [Abstract][Full Text] [Related]
5. Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon.
McDermott A
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34011611
[No Abstract] [Full Text] [Related]
6. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
[TBL] [Abstract][Full Text] [Related]
7. Herd immunization with childhood vaccination may provide protection against COVID-19.
Yu Y
Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
[TBL] [Abstract][Full Text] [Related]
9. Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects.
Bicher M; Rippinger C; Schneckenreither G; Weibrecht N; Urach C; Zechmeister M; Brunmeir D; Huf W; Popper N
Sci Rep; 2022 Feb; 12(1):2872. PubMed ID: 35190590
[TBL] [Abstract][Full Text] [Related]
10. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
11. What Is Herd Immunity?
Desai AN; Majumder MS
JAMA; 2020 Nov; 324(20):2113. PubMed ID: 33074287
[No Abstract] [Full Text] [Related]
12. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA
Front Public Health; 2021; 9():709369. PubMed ID: 34368071
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccinations: The unknowns, challenges, and hopes.
Mohamed K; Rzymski P; Islam MS; Makuku R; Mushtaq A; Khan A; Ivanovska M; Makka SA; Hashem F; Marquez L; Cseprekal O; Filgueiras IS; Fonseca DLM; Mickael E; Ling I; Arero AG; Cuschieri S; Minakova K; Rodríguez-Román E; Abarikwu SO; Faten AB; Grancini G; Cabral-Marques O; Rezaei N
J Med Virol; 2022 Apr; 94(4):1336-1349. PubMed ID: 34845731
[TBL] [Abstract][Full Text] [Related]
14. Herd immunity: challenges and the way forward in Korea.
Oh J; Kim S; Ryu B; Shin M; Kim BI
Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
[TBL] [Abstract][Full Text] [Related]
15. Five reasons why COVID herd immunity is probably impossible.
Aschwanden C
Nature; 2021 Mar; 591(7851):520-522. PubMed ID: 33737753
[No Abstract] [Full Text] [Related]
16. Analyses of Confirmed COVID-19 Cases Among Korean Military Personnel After Mass Vaccination.
Shin DH; Oh HS; Jang H; Lee S; Choi BS; Kim D
J Korean Med Sci; 2022 Jan; 37(3):e23. PubMed ID: 35040298
[TBL] [Abstract][Full Text] [Related]
17. Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination.
Chen JM; Sun YX; Chen JW
J Med Virol; 2020 Nov; 92(11):2453-2457. PubMed ID: 32525587
[TBL] [Abstract][Full Text] [Related]
18. Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.
Voigt A; Omholt S; Almaas E
PLoS One; 2022; 17(2):e0263155. PubMed ID: 35108311
[TBL] [Abstract][Full Text] [Related]
19. Could COVID-19 be contained in poor populations by herd immunity rather than by strategies designed for affluent societies or potential vaccine(s)?
Ruppel A; Halim MI; Kikon R; Mohamed NS; Saebipour MR
Glob Health Action; 2021 Jan; 14(1):1863129. PubMed ID: 33397199
[No Abstract] [Full Text] [Related]
20. COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects.
Wong RSY
Malays J Pathol; 2021 Aug; 43(2):203-217. PubMed ID: 34448786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]